SPRED3

SPRED3
Identifiers
Aliases	SPRED3, Eve-3, spred-3, sprouty related EVH1 domain containing 3
External IDs	OMIM: 609293 MGI: 2142186 HomoloGene: 28061 GeneCards: SPRED3
Gene location (Human)
Chr.	Chromosome 19 (human)[1]
End	38,399,587 bp[1]
Gene location (Mouse)
Chr.	Chromosome 7 (mouse)[2]
End	29,170,411 bp[2]
Gene ontology
Molecular function	• protein kinase binding;
Cellular component	• membrane;
Biological process	• multicellular organism development; • regulation of signal transduction; • inactivation of MAPK activity; • negative regulation of peptidyl-threonine phosphorylation; • positive regulation of DNA damage response, signal transduction by p53 class mediator; • regulation of protein deacetylation;
	Sources:Amigo / QuickGO
Orthologs
	399473
	101809
	ENSG00000188766
	ENSMUSG00000037239
	Q2MJR0
	Q6P6N5
	NM_001039616; NM_001042522
	NM_182927
	NP_001035987
	NP_891557
	Wikidata
View/Edit Human	View/Edit Mouse

Sprouty-related, EVH1 domain-containing protein 3 also known as Spread-3 is a protein that in humans is encoded by the SPRED3 gene.[5]

Spread-3 is a member of the Sprouty (see SPRY1/SPRED) family of proteins that regulate growth factor-induced activation of the MAP kinase cascade.[5][6]

References

GRCh38: Ensembl release 89: ENSG00000188766 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000037239 - Ensembl, May 2017
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: sprouty-related".
Nonami A, Kato R, Taniguchi K, Yoshiga D, Taketomi T, Fukuyama S, Harada M, Sasaki A, Yoshimura A (December 2004). "Spred-1 negatively regulates interleukin-3-mediated ERK/mitogen-activated protein (MAP) kinase activation in hematopoietic cells". The Journal of Biological Chemistry. 279 (50): 52543–51. doi:10.1074/jbc.M405189200. PMID 15465815.

Kato R, Nonami A, Taketomi T, Wakioka T, Kuroiwa A, Matsuda Y, Yoshimura A (March 2003). "Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation". Biochemical and Biophysical Research Communications. 302 (4): 767–72. doi:10.1016/S0006-291X(03)00259-6. PMID 12646235.
Mizoguchi M, Nutt CL, Louis DN (February 2004). "Mutation analysis of CBL-C and SPRED3 on 19q in human glioblastoma". Neurogenetics. 5 (1): 81–2. doi:10.1007/s10048-003-0164-x. PMID 14618415. S2CID 35025882.
King JA, Corcoran NM, D'Abaco GM, Straffon AF, Smith CT, Poon CL, Buchert M, I S, Hall NE, Lock P, Hovens CM (April 2006). "Eve-3: a liver enriched suppressor of Ras/MAPK signaling". Journal of Hepatology. 44 (4): 758–67. doi:10.1016/j.jhep.2005.10.031. PMID 16478641.
Lock P, I ST, Straffon AF, Schieb H, Hovens CM, Stylli SS (December 2006). "Spred-2 steady-state levels are regulated by phosphorylation and Cbl-mediated ubiquitination". Biochemical and Biophysical Research Communications. 351 (4): 1018–23. doi:10.1016/j.bbrc.2006.10.150. PMID 17094949.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.